Skip to main content
Top
Published in: Radiation Oncology 1/2023

Open Access 01-12-2023 | Lymphopenia | Research

Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organs

Authors: Ihsuan Tseng, Dashan Ai, Yun Chen, Hongcheng Zhu, Fangfang Li, Yang Xu, Lu Yu, Qi Liu, Jiaying Deng, Shengnan Hao, Zhengfei Zhu, Weixin Zhao, Min Fan, Ling Li, Fengtao Su, Kuaile Zhao

Published in: Radiation Oncology | Issue 1/2023

Login to get access

Abstract

Background

Limited studies explored the relationship between lymphocyte recovery after definitive concurrent chemoradiotherapy (dCCRT) and prognosis in esophageal squamous cell carcinoma (ESCC).

Methods

ESCC patients with obtainable absolute lymphocyte counts (ALCs) at 6 months after dCCRT were screened from prospective trials. Patients were divided into groups according to the grade of ALC nadir during radiotherapy (G4 or G1–3) and lymphocyte recovery status, which was assessed by lymphocyte recovery index (LRI), calculated as the ratio of post- to pre-treatment lymphocyte counts. Cox analysis was conducted to evaluate the prognostic significance of lymphocyte recovery status. Irradiated relative volumes of the bone marrow (BM) and spleen and effective dose to immune cells (EDIC) were collected to identify their impacts on lymphocyte recovery status by logistic analysis.

Results

232 patients were enrolled. In 69 patients with G4 ALC nadir (group A and B) and 163 patients with G1–3 ALC nadir (group C and D) during dCCRT, 27 (group A) and 67 (group C) patients showed an insufficient level of lymphocyte recovery (LRI < 60%), and 42 (group B) and 96 (group D) patients showed a satisfactory level of lymphocyte recovery (LRI ≥ 60%). Cox multivariable analysis revealed that inadequate lymphocyte recovery was significantly associated with worse overall survival (HR, 2.80 and 1.70) and local recurrence-free survival (HR, 2.82 and 1.60) both in group A vs group B and group C vs group D. Logistic analysis identified BM V5 (OR 4.24 and 2.29) as an independent predictor of inadequate lymphocyte recovery from G4 or G1–3 ALC nadir, respectively.

Conclusions

Insufficient lymphocyte recovery might serve as a valuable prognostic factor, regardless of whether patients experienced G4 or G1–3 ALC nadir during radiotherapy. Additionally, it was observed that a larger relative volume of BM receiving ≥ 5 Gy was correlated with a higher risk of insufficient lymphocyte recovery.
Appendix
Available only for authorised users
Literature
1.
go back to reference Weichselbaum RR, Liang H, Deng L, et al. Radiotherapy and immunotherapy: a beneficial liaison? Nat Rev Clin Oncol. 2017;14(6):365–79.CrossRefPubMed Weichselbaum RR, Liang H, Deng L, et al. Radiotherapy and immunotherapy: a beneficial liaison? Nat Rev Clin Oncol. 2017;14(6):365–79.CrossRefPubMed
2.
go back to reference Grassberger C, Ellsworth SG, Wilks MQ, et al. Assessing the interactions between radiotherapy and antitumour immunity. Nat Rev Clin Oncol. 2019;16(12):729–45.CrossRefPubMed Grassberger C, Ellsworth SG, Wilks MQ, et al. Assessing the interactions between radiotherapy and antitumour immunity. Nat Rev Clin Oncol. 2019;16(12):729–45.CrossRefPubMed
3.
go back to reference Marciscano AE, Ghasemzadeh A, Nirschl TR, et al. Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy. Clin Cancer Res. 2018;24(20):5058–71.CrossRefPubMedPubMedCentral Marciscano AE, Ghasemzadeh A, Nirschl TR, et al. Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy. Clin Cancer Res. 2018;24(20):5058–71.CrossRefPubMedPubMedCentral
4.
go back to reference Yovino S, Grossman SA. Severity, etiology and possible consequences of treatment-related lymphopenia in patients with newly diagnosed high-grade gliomas. CNS Oncol. 2012;1(2):149–54.CrossRefPubMedPubMedCentral Yovino S, Grossman SA. Severity, etiology and possible consequences of treatment-related lymphopenia in patients with newly diagnosed high-grade gliomas. CNS Oncol. 2012;1(2):149–54.CrossRefPubMedPubMedCentral
5.
go back to reference Heier HE, Christensen I, Froland SS, et al. Early and late effects of irradiation for seminoma testis on the number of blood lymphocytes and their B and T subpopulations. Lymphology. 1975;8(3):69.PubMed Heier HE, Christensen I, Froland SS, et al. Early and late effects of irradiation for seminoma testis on the number of blood lymphocytes and their B and T subpopulations. Lymphology. 1975;8(3):69.PubMed
6.
go back to reference Lee BM, Byun HK, Seong J. Significance of lymphocyte recovery from treatment-related lymphopenia in locally advanced pancreatic cancer. Radiother Oncol. 2020;151:82–7.CrossRefPubMed Lee BM, Byun HK, Seong J. Significance of lymphocyte recovery from treatment-related lymphopenia in locally advanced pancreatic cancer. Radiother Oncol. 2020;151:82–7.CrossRefPubMed
7.
go back to reference Deng W, Xu C, Liu A, et al. The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy. Radiother Oncol. 2019;133:9–15.CrossRefPubMed Deng W, Xu C, Liu A, et al. The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy. Radiother Oncol. 2019;133:9–15.CrossRefPubMed
8.
go back to reference Chen Y, Ye J, Zhu Z, et al. Comparing paclitaxel plus fluorouracil versus cisplatin plus fluorouracil in chemoradiotherapy for locally advanced esophageal squamous cell cancer: a randomized, multicenter, phase III clinical trial. J Clin Oncol. 2019;37(20):1695–703.CrossRefPubMedPubMedCentral Chen Y, Ye J, Zhu Z, et al. Comparing paclitaxel plus fluorouracil versus cisplatin plus fluorouracil in chemoradiotherapy for locally advanced esophageal squamous cell cancer: a randomized, multicenter, phase III clinical trial. J Clin Oncol. 2019;37(20):1695–703.CrossRefPubMedPubMedCentral
9.
go back to reference Ai D, Ye J, Wei S, et al. Comparison of 3 paclitaxel-based chemoradiotherapy regimens for patients with locally advanced esophageal squamous cell cancer: a randomized clinical trial. JAMA Netw Open. 2022;5(2): e220120.CrossRefPubMedPubMedCentral Ai D, Ye J, Wei S, et al. Comparison of 3 paclitaxel-based chemoradiotherapy regimens for patients with locally advanced esophageal squamous cell cancer: a randomized clinical trial. JAMA Netw Open. 2022;5(2): e220120.CrossRefPubMedPubMedCentral
10.
go back to reference Tseng I, Li F, Ai D, Chen Y, Xu Y, Yu L, Hao S, Zhu H, Deng J, Liu Q, Pan F, Su F, Zhao K. Less irradiation to lymphocyte-related organs reduced the risk of G4 lymphopenia in esophageal cancer: re-analysis of prospective trials. Oncologist. 2023;28(8):645-652.CrossRef Tseng I, Li F, Ai D, Chen Y, Xu Y, Yu L, Hao S, Zhu H, Deng J, Liu Q, Pan F, Su F, Zhao K. Less irradiation to lymphocyte-related organs reduced the risk of G4 lymphopenia in esophageal cancer: re-analysis of prospective trials. Oncologist. 2023;28(8):645-652.CrossRef
11.
go back to reference Jin JY, Hu C, Xiao Y, et al. Higher radiation dose to the immune cells correlates with worse tumor control and overall survival in patients with stage III NSCLC: a secondary analysis of RTOG0617. Cancers (Basel). 2021;13(24):6193.CrossRefPubMed Jin JY, Hu C, Xiao Y, et al. Higher radiation dose to the immune cells correlates with worse tumor control and overall survival in patients with stage III NSCLC: a secondary analysis of RTOG0617. Cancers (Basel). 2021;13(24):6193.CrossRefPubMed
12.
go back to reference Hothorn T, Lausen B. Maximally selected rank statistics in R. R News. 2002;2(1):3–5. Hothorn T, Lausen B. Maximally selected rank statistics in R. R News. 2002;2(1):3–5.
13.
go back to reference Cho Y, Kim Y, Chamseddine I, et al. Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy. Radiother Oncol. 2022;168:1–7.CrossRefPubMedPubMedCentral Cho Y, Kim Y, Chamseddine I, et al. Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy. Radiother Oncol. 2022;168:1–7.CrossRefPubMedPubMedCentral
14.
go back to reference Verma R, Foster RE, Horgan K, et al. Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer. Breast Cancer Res BCR. 2016;18(1):10.CrossRefPubMed Verma R, Foster RE, Horgan K, et al. Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer. Breast Cancer Res BCR. 2016;18(1):10.CrossRefPubMed
15.
go back to reference Wang Q, Qiu Q, Zhang Z, et al. Bone marrow dosimetric analysis of lymphopenia in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy. Cancer Med. 2021;10(17):5847–58.CrossRefPubMedPubMedCentral Wang Q, Qiu Q, Zhang Z, et al. Bone marrow dosimetric analysis of lymphopenia in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy. Cancer Med. 2021;10(17):5847–58.CrossRefPubMedPubMedCentral
16.
go back to reference Saito T, Toya R, Yoshida N, et al. Spleen dose-volume parameters as a predictor of treatment-related lymphopenia during definitive chemoradiotherapy for esophageal cancer. In Vivo. 2018;32(6):1519–25.CrossRefPubMedPubMedCentral Saito T, Toya R, Yoshida N, et al. Spleen dose-volume parameters as a predictor of treatment-related lymphopenia during definitive chemoradiotherapy for esophageal cancer. In Vivo. 2018;32(6):1519–25.CrossRefPubMedPubMedCentral
17.
go back to reference Mussano F, Lee KJ, Zuk P, et al. Differential effect of ionizing radiation exposure on multipotent and differentiation-restricted bone marrow mesenchymal stem cells. J Cell Biochem. 2010;111(2):322–32.CrossRefPubMed Mussano F, Lee KJ, Zuk P, et al. Differential effect of ionizing radiation exposure on multipotent and differentiation-restricted bone marrow mesenchymal stem cells. J Cell Biochem. 2010;111(2):322–32.CrossRefPubMed
18.
go back to reference Noticewala SS, Li N, Williamson CW, et al. Longitudinal changes in active bone marrow for cervical cancer patients treated with concurrent chemoradiation therapy. Int J Radiat Oncol Biol Phys. 2017;97(4):797–805.CrossRefPubMed Noticewala SS, Li N, Williamson CW, et al. Longitudinal changes in active bone marrow for cervical cancer patients treated with concurrent chemoradiation therapy. Int J Radiat Oncol Biol Phys. 2017;97(4):797–805.CrossRefPubMed
19.
go back to reference Sun GY, Wang SL, Song YW, et al. Radiation-induced lymphopenia predicts poorer prognosis in patients with breast cancer: a post hoc analysis of a randomized controlled trial of postmastectomy hypofractionated radiation therapy. Int J Radiat Oncol Biol Phys. 2020;108(1):277–85.CrossRefPubMed Sun GY, Wang SL, Song YW, et al. Radiation-induced lymphopenia predicts poorer prognosis in patients with breast cancer: a post hoc analysis of a randomized controlled trial of postmastectomy hypofractionated radiation therapy. Int J Radiat Oncol Biol Phys. 2020;108(1):277–85.CrossRefPubMed
20.
go back to reference Okazaki R, Mabuchi Y, Yoshida Y, et al. The late effects of radiation on lifespan, lymphocyte proliferation and p53 haplodeficiency in mice. Int J Radiat Biol. 2010;86(11):927–34.CrossRefPubMed Okazaki R, Mabuchi Y, Yoshida Y, et al. The late effects of radiation on lifespan, lymphocyte proliferation and p53 haplodeficiency in mice. Int J Radiat Biol. 2010;86(11):927–34.CrossRefPubMed
Metadata
Title
Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organs
Authors
Ihsuan Tseng
Dashan Ai
Yun Chen
Hongcheng Zhu
Fangfang Li
Yang Xu
Lu Yu
Qi Liu
Jiaying Deng
Shengnan Hao
Zhengfei Zhu
Weixin Zhao
Min Fan
Ling Li
Fengtao Su
Kuaile Zhao
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2023
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-023-02354-w

Other articles of this Issue 1/2023

Radiation Oncology 1/2023 Go to the issue